|
ARTH Arch Therapeutics Inc 1537561 |
| Income Statement |
|
Revenue
|
form10-q
|
30,913 |
|
Net Income
|
form10-q
|
-5,654,681 |
|
Profit Margin
|
|
-18292.24% |
| Balance Sheet |
|
Current Assets
|
1,391,130 |
|
Assets
|
1,397,644 |
|
Current Liabilities
|
13,958,210 |
|
Liabilities
|
13,958,210 |
|
Equity
|
-12,560,566 |
|
Shares Out
|
4,444,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,474,405 |
| Market Analysis |
Market Cap
|
3,288,826 |
|
Price
|
0.25 |
|
PB
|
2500.00 |
|
EPS
|
-3.69 |
|
PS
|
26.60 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARTH documents filed with the SEC.
ARTH Filings
Clear
